An early study investigating the haemostatic balance in pancreatic cancer found that the coagulation inhibitors antithrombin III, heparin cofactor II, protein C, free protein S, and thrombomodulin were significantly decreased during the progression of pancreatic cancer after diagnosis [141]. Here, SERPIND1 is linked to familial pancreatic carcinoma.